Madrigal Pharmaceuticals Inc
NASDAQ:MDGL

Watchlist Manager
Madrigal Pharmaceuticals Inc Logo
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
Watchlist
Price: 342.44 USD -1.7% Market Closed
Market Cap: 7.6B USD

Intrinsic Value

The intrinsic value of one MDGL stock under the Base Case scenario is 465.74 USD. Compared to the current market price of 342.44 USD, Madrigal Pharmaceuticals Inc is Undervalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDGL Intrinsic Value
465.74 USD
Undervaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Madrigal Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MDGL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MDGL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
US
Biotechnology
Market Cap
7.5B USD
IPO
Feb 6, 2007
US
Biotechnology
Market Cap
7.5B USD
IPO
Feb 6, 2007
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MDGL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Madrigal Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Madrigal Pharmaceuticals Inc

Current Assets 1.1B
Cash & Short-Term Investments 998.6m
Receivables 30.5m
Other Current Assets 34.6m
Non-Current Assets 9.6m
PP&E 4.8m
Intangibles 4.8m
Efficiency

Free Cash Flow Analysis
Madrigal Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Madrigal Pharmaceuticals Inc

Revenue
180.1m USD
Cost of Revenue
-6.2m USD
Gross Profit
173.9m USD
Operating Expenses
-671.8m USD
Operating Income
-497.9m USD
Other Expenses
32m USD
Net Income
-465.9m USD
Fundamental Scores

MDGL Profitability Score
Profitability Due Diligence

Madrigal Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
ROE is Increasing
Positive Gross Profit
38/100
Profitability
Score

Madrigal Pharmaceuticals Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

MDGL Solvency Score
Solvency Due Diligence

Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
86/100
Solvency
Score

Madrigal Pharmaceuticals Inc's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDGL Price Targets Summary
Madrigal Pharmaceuticals Inc

Wall Street analysts forecast MDGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDGL is 414.73 USD with a low forecast of 241.39 USD and a high forecast of 565.95 USD.

Lowest
Price Target
241.39 USD
30% Downside
Average
Price Target
414.73 USD
21% Upside
Highest
Price Target
565.95 USD
65% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Madrigal Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MDGL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

MDGL Insider Trading
Buy and sell transactions by insiders

MDGL News

Other Videos
What is the Intrinsic Value of one MDGL stock?

The intrinsic value of one MDGL stock under the Base Case scenario is 465.74 USD.

Is MDGL stock undervalued or overvalued?

Compared to the current market price of 342.44 USD, Madrigal Pharmaceuticals Inc is Undervalued by 26%.

Back to Top